To discuss the challenges limiting the adoption of AI technologies, such as AI-enabled ultrasound and multimodal data integration, in thyroid care despite their advancements.
Key Findings:
Current AI models in thyroid care often fall short in performance and usability, impacting clinical decision-making.
Economic barriers exist due to unclear return on investment for institutions, hindering widespread adoption.
Emerging AI technologies, such as AI-enabled ultrasound and multimodal data integration, show promise but have limitations that need addressing.
Many AI tools lack prospective validation in real-world clinical settings, raising concerns about their reliability.
Interpretation:
The integration of AI in thyroid care is hindered by performance issues, economic factors, and a lack of rigorous validation, despite the potential benefits of new technologies that could enhance patient outcomes.
Limitations:
AI models may increase clinical workload rather than reduce it, complicating the workflow for healthcare providers.
Strong performance in controlled settings does not guarantee effectiveness in real-world applications, which is critical for patient safety.
Evidence gaps exist regarding the prospective validation of AI tools, which could lead to misinformed clinical decisions.
Conclusion:
For AI innovations in endocrinology to be effective, they must be validated rigorously, integrated seamlessly into workflows, demonstrate clear clinical value, and address economic barriers to adoption.
